Royal London Asset Management LTD Bristol Myers Squibb CO Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Royal London Asset Management LTD holds 1,548,855 shares of BMY stock, worth $91.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,548,855

Previous 1,536,894 0.78%

Holding current value

$91.5 Million

Previous $63.8 Million 25.58%

% of portfolio

0.2%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $474,373 - $618,981	11,961 Added 0.78%	1,548,855 $80.2 Million
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $6.69 Million - $8.81 Million	-166,286 Reduced 9.76%	1,536,894 $63.8 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $3.41 Million - $3.86 Million	71,008 Added 4.35%	1,703,180 $92.4 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $2.09 Million - $2.5 Million	43,204 Added 2.72%	1,632,172 $83.7 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $9.35 Million - $10.5 Million	161,575 Added 11.32%	1,588,968 $92.2 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $14.5 Million - $16.1 Million	227,724 Added 18.98%	1,427,393 $91.3 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $29.9 Million - $33.9 Million	455,123 Added 61.13%	1,199,669 $83.1 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $896,608 - $1.06 Million	13,093 Added 1.79%	744,546 $53.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $6,736 - $3.98 Million	-51,822 Reduced 6.62%	731,453 $52 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $188,812 - $207,948	2,600 Added 0.33%	783,275 $60.4 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $355,661 - $426,470	5,785 Added 0.75%	780,675 $57 Million
Q4 2021 Oct 18, 2022	SELL	$53.63 - $62.52 $1.16 Million - $1.35 Million	-21,604 Reduced 2.71%	774,890 $48.3 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $1.16 Million - $1.35 Million	-21,604 Reduced 2.71%	774,890 $48.3 Million
Q3 2021 Oct 18, 2022	SELL	$59.17 - $69.31 $1.14 Million - $1.34 Million	-19,304 Reduced 2.37%	796,494 $47.1 Million
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $1.14 Million - $1.34 Million	-19,304 Reduced 2.37%	796,494 $47.1 Million
Q2 2021 Oct 18, 2022	BUY	$61.91 - $67.42 $2.01 Million - $2.19 Million	32,523 Added 4.15%	815,798 $54.5 Million
Q2 2021 Jul 14, 2021	SELL	$61.91 - $67.42 $2.35 Million - $2.55 Million	-37,880 Reduced 4.44%	815,798 $54.3 Million
Q1 2021 Oct 17, 2022	BUY	$59.34 - $66.74 $4.18 Million - $4.7 Million	70,403 Added 8.99%	853,678 $53.9 Million
Q1 2021 Apr 13, 2021	BUY	$59.34 - $66.74 $1.43 Million - $1.61 Million	24,076 Added 2.9%	853,678 $53.9 Million
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $2.3 Million - $2.6 Million	-39,780 Reduced 4.58%	829,602 $51.4 Million
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $1.03 Million - $1.14 Million	-17,990 Reduced 2.03%	869,382 $52.1 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $2.19 Million - $2.56 Million	-39,932 Reduced 4.31%	887,372 $51.3 Million
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $204,624 - $297,366	-4,410 Reduced 0.47%	927,304 $50.5 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $14.1 Million - $18.4 Million	286,360 Added 44.37%	931,714 $59.4 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $463,712 - $549,797	-10,842 Reduced 1.65%	645,354 $32.7 Million
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $498,539 - $551,275	-11,173 Reduced 1.67%	656,196 $29.7 Million
Q1 2019 Apr 30, 2019	SELL	$45.12 - $53.8 $1.03 Million - $1.23 Million	-22,785 Reduced 3.3%	667,369 $0
Q4 2018 Jan 29, 2019	BUY	$48.76 - $63.23 $33.7 Million - $43.6 Million	690,154 New	690,154 $35.2 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $37.7 Million - $42.6 Million	-683,995 Closed	0 $0
Q2 2018 Sep 19, 2018	BUY	$50.53 - $62.98 $34.6 Million - $43.1 Million	683,995 New	683,995 $37.9 Million

Others Institutions Holding BMY

# of Institutions

2,586

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Bristol Myers Squibb CO Transaction History